Sheng-Wei Chang, PhD., CGMBS, is a Clinical Laboratory Scientist currently employed at Labcorp since October 2024, with prior experience at Bionano Genomics, Inc., and Fulgent Genetics, where expertise was developed in Next Generation Sequencing (NGS) technologies and clinical genetic variant identification. Academic training includes a PhD in Molecular, Cellular, and Developmental Biology from The Ohio State University, complemented by extensive research roles at City of Hope and Nationwide Children's Hospital, focusing on molecular biology, cancer metabolism, and cystic fibrosis, along with contributions to national conferences. Professional background also encompasses teaching experience as a Graduate Teaching Assistant at The Ohio State University.